These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 27094018)

  • 1. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.
    Suzuki A; Taniguchi H; Watanabe N; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Nishiyama O; Hasegawa Y
    PLoS One; 2014; 9(9):e108339. PubMed ID: 25268705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
    Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
    Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
    Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of interstitial lung disease associated with connective tissue disease.
    Mathai SC; Danoff SK
    BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between miR-200c and the severity of interstitial lung disease associated with different connective tissue diseases.
    Jiang Z; Tao JH; Zuo T; Li XM; Wang GS; Fang X; Xu XL; Li XP
    Scand J Rheumatol; 2017 Mar; 46(2):122-129. PubMed ID: 27309544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic heterogeneity of connective tissue disease patients with borderline mean pulmonary artery pressure and its distinctive characters from those with normal pulmonary artery pressure: a retrospective study.
    Asari Y; Yamasaki Y; Tsuchida K; Suzuki K; Akashi YJ; Okazaki T; Ozaki S; Yamada H; Kawahata K
    Clin Rheumatol; 2018 Dec; 37(12):3373-3380. PubMed ID: 29777409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
    Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
    Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
    Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
    BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
    Vij R; Strek ME
    Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases.
    Parambil JG; Myers JL; Ryu JH
    Chest; 2006 Aug; 130(2):553-8. PubMed ID: 16899858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
    Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
    Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement.
    Antoniou KM; Margaritopoulos G; Economidou F; Siafakas NM
    Eur Respir J; 2009 Apr; 33(4):882-96. PubMed ID: 19336591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining respiratory impairment in connective tissue disease-associated interstitial lung disease.
    Assayag D; Ryerson CJ
    Rheum Dis Clin North Am; 2015 May; 41(2):213-23. PubMed ID: 25836638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for the treatment of connective tissue disease-associated interstitial lung disease.
    Chartrand S; Swigris JJ; Peykova L; Fischer A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):296-304. PubMed ID: 26847096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.